Abstract
Public health and social measures (PHSM), such as adaptions to the operation of schools, businesses and workplaces, international travel measures and restrictions on gatherings and people’s movements, as well as individual preventive measures such as physical distancing, have been a vital set of tools utilized by many countries to mitigate the spread of SARS-CoV-2 virus throughout the COVID-19 pandemic. In January 2020, the WHO Regional Office for Europe started to systematically monitor, collect and categorize data on response measures taken by its Member States. In order to visualize and analyse the collected data, WHO developed a methodology for quantifying the response measures into an index, capturing the severity of these policy measures in terms of six key indicators. The aim of this article is to describe the methodology underlying the index, including data collection, categorization and calculation, in order to provide researchers and policy-makers with a better understanding of its application. Furthermore, it provides an overview and examples of possible applications of the index, as well as serve as a reference for subsequent research on the effectiveness of PHSM, including empirical studies and models that can help to guide health policies, their timing and severity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Disclaimer The authors are staff members of the World Health Organization. The authors alone are responsible for the views expressed in this publication and they do not necessarily represent the decisions or policies of the World Health Organization.
Data Availability
All data produced in the present work are available on the WHO/EURO PHSM in Response to COVID-19 Platform.
